Carole Colin

4.7k total citations
79 papers, 2.8k citations indexed

About

Carole Colin is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Carole Colin has authored 79 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 26 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Carole Colin's work include Glioma Diagnosis and Treatment (44 papers), Cancer Cells and Metastasis (10 papers) and Neuroblastoma Research and Treatments (10 papers). Carole Colin is often cited by papers focused on Glioma Diagnosis and Treatment (44 papers), Cancer Cells and Metastasis (10 papers) and Neuroblastoma Research and Treatments (10 papers). Carole Colin collaborates with scholars based in France, Germany and United States. Carole Colin's co-authors include Dominique Figarella‐Branger, Karima Mokhtari, L’Houcine Ouafik, Philippe Métellus, Aurélie Tchoghandjian, Corinne Bouvier, Olivier Chinot, Nathalie Baeza, Fréderic Fina and Anderson Loundou and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Carole Colin

78 papers receiving 2.8k citations

Peers

Carole Colin
Binish Rasheed United States
Tomoko Ozawa United States
Wang Jia China
Takao Hoshino United States
Ranjit S. Bindra United States
Yiting Cao United States
Mikael L. Rinne United States
Raju R. Raval United States
Binish Rasheed United States
Carole Colin
Citations per year, relative to Carole Colin Carole Colin (= 1×) peers Binish Rasheed

Countries citing papers authored by Carole Colin

Since Specialization
Citations

This map shows the geographic impact of Carole Colin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Colin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Colin more than expected).

Fields of papers citing papers by Carole Colin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Colin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Colin. The network helps show where Carole Colin may publish in the future.

Co-authorship network of co-authors of Carole Colin

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Colin. A scholar is included among the top collaborators of Carole Colin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Colin. Carole Colin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figarella‐Branger, Dominique, Caroline Dehais, Carole Colin, & François Ducray. (2025). Reply to “The time has come for an integrated and multiscale grading system for oligodendrogliomas IDH-mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters”. Neuro-Oncology. 27(4). 1130–1131.
2.
Baeza-Kallee, Nathalie, Raphaël Bergès, Carole Colin, et al.. (2025). The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells. Cancer Cell International. 25(1). 246–246. 1 indexed citations
3.
Joseph, Kevin, Carole Colin, Hervé Luche, et al.. (2024). SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment. Cell Death and Disease. 15(9). 676–676. 3 indexed citations
4.
Baeza-Kallee, Nathalie, Carole Colin, Paulina A García-González, et al.. (2024). Metabolic adaptation of myeloid cells in the glioblastoma microenvironment. Frontiers in Immunology. 15. 1431112–1431112. 1 indexed citations
5.
Baeza-Kallee, Nathalie, et al.. (2024). GD3 ganglioside is a promising therapeutic target for glioma patients.. Neuro-Oncology Advances. 6(1). vdae038–vdae038. 3 indexed citations
6.
Baeza-Kallee, Nathalie, Raphaël Bergès, Stéphanie Cabaret, et al.. (2023). Deciphering the Action of Neuraminidase in Glioblastoma Models. International Journal of Molecular Sciences. 24(14). 11645–11645. 7 indexed citations
7.
Figarella‐Branger, Dominique, Carole Colin, Nathalie Baeza-Kallee, & Aurélie Tchoghandjian. (2022). A2B5 Expression in Central Nervous System and Gliomas. International Journal of Molecular Sciences. 23(9). 4670–4670. 9 indexed citations
8.
Métais, Alice, Romain Appay, Mélanie Pagès, et al.. (2021). Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges. Neuropathology and Applied Neurobiology. 48(2). e12769–e12769. 8 indexed citations
9.
Appay, Romain, Alice Métais, Arnault Tauziède‐Espariat, et al.. (2021). La classification de l’OMS 2021 des tumeurs du système nerveux central. Annales de Pathologie. 42(5). 367–382. 41 indexed citations
10.
Appay, Romain, Mélanie Pagès, Carole Colin, et al.. (2020). Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases. Acta Neuropathologica Communications. 8(1). 95–95. 23 indexed citations
12.
Padovani, Laëtitia, Carole Colin, Manon Carré, et al.. (2013). Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma. Acta Neuropathologica Communications. 1(1). 17–17. 8 indexed citations
13.
Métellus, Philippe, Isabelle Nanni‐Metellus, Christine Delfino, et al.. (2011). Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution. Annals of Surgical Oncology. 18(10). 2937–2945. 51 indexed citations
14.
Métellus, Philippe, Carole Colin, David Taïeb, et al.. (2011). IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients. Journal of Neuro-Oncology. 105(3). 591–600. 57 indexed citations
15.
Hallani, Soufiane El, Blandine Boisselier, Florent Péglion, et al.. (2010). A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain. 133(4). 973–982. 284 indexed citations
16.
Tchoghandjian, Aurélie, C. Fernandez, Carole Colin, et al.. (2009). Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature. Brain. 132(6). 1523–1535. 46 indexed citations
17.
Tchoghandjian, Aurélie, Nathalie Baeza, Carole Colin, et al.. (2009). A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties. Brain Pathology. 20(1). 211–221. 144 indexed citations
18.
Colin, Carole, Brigitte Voutsinos‐Porche, Isabelle Nanni, et al.. (2009). High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathologica. 118(6). 745–754. 56 indexed citations
19.
Bouvier, Corinne, Agnès Liprandi, Carole Colin, et al.. (2005). Lack of Alkaline Phosphatase Activity Predicts Meningioma Recurrence. American Journal of Clinical Pathology. 124(2). 252–258. 10 indexed citations
20.
Haupt, Karsten, et al.. (1996). Immobilized metal ion affinity gel electrophoresis: Quantification of protein affinity to transition metal chelates. Electrophoresis. 17(3). 489–492. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026